Cellev8 Nutrition Files Two Patents at US Trademark and Patent Office
Cellev8 Nutrition Inc (OTC PINK:CELV) has filed two patents at the US Trademark and Patent Office for its innovative supplement delivery systems. The patents focus on enhancing the transport of Superoxide Dismutase (SOD) and other ingredients throughout the body. The patent-pending formulations aim to improve absorption and utilization of key ingredients, particularly in their SOD formulations.
The company's delivery mechanisms have demonstrated effectiveness across thousands of users, targeting oxidative stress reduction and cellular protection. The technology will be applied across Cellev8's product range, including inflammation and recovery, focus and memory, and GLP1 support gummies. The company currently serves thousands of customers, including over 40 professional and collegiate athletic teams, and maintains partnerships with FDA-certified companies.
Cellev8 Nutrition Inc (OTC PINK:CELV) ha presentato due brevetti presso l'Ufficio Brevetti e Marchi degli Stati Uniti per i suoi innovativi sistemi di somministrazione di integratori. I brevetti si concentrano sul miglioramento del trasporto della Superossido Dismutasi (SOD) e di altri ingredienti in tutto il corpo. Le formulazioni in attesa di brevetto mirano a migliorare l'assorbimento e l'utilizzo di ingredienti chiave, in particolare nelle loro formulazioni di SOD.
I meccanismi di somministrazione dell'azienda hanno dimostrato efficacia su migliaia di utenti, mirando a ridurre lo stress ossidativo e a proteggere le cellule. Questa tecnologia sarà applicata all'intera gamma di prodotti di Cellev8, compresi i gommose per infiammazione e recupero, concentrazione e memoria, e supporto GLP1. L'azienda attualmente serve migliaia di clienti, inclusi oltre 40 team sportivi professionali e universitari, e mantiene partnership con aziende certificate dalla FDA.
Cellev8 Nutrition Inc (OTC PINK:CELV) ha presentado dos patentes ante la Oficina de Marcas y Patentes de EE. UU. para sus innovativos sistemas de entrega de suplementos. Las patentes se centran en mejorar el transporte de la Superóxido Dismutasa (SOD) y otros ingredientes a lo largo del cuerpo. Las formulaciones pendientes de patente tienen como objetivo mejorar la absorción y utilización de ingredientes clave, especialmente en sus formulaciones de SOD.
Los mecanismos de entrega de la compañía han demostrado eficacia en miles de usuarios, enfocándose en la reducción del estrés oxidativo y la protección celular. La tecnología se aplicará en toda la gama de productos de Cellev8, incluidos gomitas para inflamación y recuperación, concentración y memoria, y apoyo GLP1. La empresa actualmente atiende a miles de clientes, incluidos más de 40 equipos deportivos profesionales y universitarios, y mantiene asociaciones con empresas certificadas por la FDA.
Cellev8 Nutrition Inc (OTC PINK:CELV)는 미국 특허청에 혁신적인 보충제 전달 시스템에 대한 두 개의 특허를 출원했습니다. 이 특허는 슈퍼옥사이드 디스무타제(SOD)와 기타 성분의 몸 전체에 대한 운반 향상에 중점을 두고 있습니다. 특허 출원 중인 제형은 특히 SOD 제형에서 주요 성분의 흡수 및 활용을 개선하는 것을 목표로 합니다.
회사의 전달 메커니즘은 수천 명의 사용자에게 효과를 입증하며, 산화 스트레스 감소 및 세포 보호를 목표로 하고 있습니다. 이 기술은 염증 및 회복, 집중력 및 기억력, GLP1 지원 구미를 포함한 Cellev8의 제품 범위 전반에 적용될 예정입니다. 이 회사는 현재 40개 이상의 전문 및 대학 운동 팀을 포함해 수천 명의 고객에게 서비스를 제공하고 있으며, FDA 인증을 받은 회사와의 파트너십을 유지하고 있습니다.
Cellev8 Nutrition Inc (OTC PINK:CELV) a déposé deux brevets auprès de l'Office des brevets et des marques des États-Unis pour ses systèmes de livraison de suppléments innovants. Les brevets se concentrent sur l'amélioration du transport de la superoxyde dismutase (SOD) et d'autres ingrédients dans le corps. Les formulations en attente de brevet visent à améliorer l'absorption et l'utilisation d'ingrédients clés, en particulier dans leurs formulations de SOD.
Les mécanismes de livraison de l'entreprise ont démontré leur efficacité auprès de milliers d'utilisateurs, ciblant la réduction du stress oxydatif et la protection cellulaire. La technologie sera appliquée à l'ensemble de la gamme de produits de Cellev8, y compris des gommes pour l'inflammation et la récupération, la concentration et la mémoire, ainsi que des gommes de soutien GLP1. L'entreprise dessert actuellement des milliers de clients, dont plus de 40 équipes sportives professionnelles et universitaires, et maintient des partenariats avec des entreprises certifiées par la FDA.
Cellev8 Nutrition Inc (OTC PINK:CELV) hat beim US-Patent- und Markenamt zwei Patente für seine innovativen Nahrungsergänzungsmittel-Abgabesysteme angemeldet. Die Patente konzentrieren sich auf die Verbesserung des Transports von Superoxiddismutase (SOD) und anderen Inhaltsstoffen im gesamten Körper. Die patentierten Formulierungen zielen darauf ab, die Aufnahme und Nutzung wichtiger Inhaltsstoffe, insbesondere in ihren SOD-Formulierungen, zu verbessern.
Die Abgabemechanismen des Unternehmens haben sich bei Tausenden von Nutzern als effektiv erwiesen und zielen auf die Reduzierung von oxidativem Stress und den Zellschutz ab. Die Technologie wird in der gesamten Produktpalette von Cellev8 angewendet, einschließlich Gummis zur Linderung von Entzündungen und zur Regeneration, für Konzentration und Gedächtnis sowie Gummis zur GLP1-Unterstützung. Das Unternehmen bedient derzeit Tausende von Kunden, darunter über 40 professionelle und universitäre Sportteams, und pflegt Partnerschaften mit von der FDA zertifizierten Unternehmen.
- Filed two patents to protect proprietary delivery systems technology
- Technology proven effective across thousands of users
- Serves over 40 professional and collegiate athletic teams
- Potential for collaborations with larger nutraceutical and pharmaceutical companies
- None.
WELLINGTON, FL / ACCESSWIRE / December 17, 2024 / Cellev8 Nutrition Inc (OTC PINK:CELV), a pioneer in Superoxide Dismutase (SOD) based supplements, has announced the filing of two patents to protect its groundbreaking delivery systems. These patents are set to revolutionize the company's product lines and enhance the proprietary transport of SOD and other powerful ingredients throughout the body to enhance wellness, and promote health and anti aging from cellular levels.
Advancing Supplement Technology
The patent-pending formulations represent a significant leap forward in supplement technology worldwide. Cellev8's delivery mechanisms have proven effect with thousands of people by focusing on reducing oxidative stress and providing superior cellular protection in the body. Cellev8 revolutionizes supplement effectiveness by employing advanced delivery mechanisms to enhance SOD absorption and combining it with powerful, targeted ingredients. This innovative approach maximizes the potency and precision of their products, delivering optimal benefits to specific areas of the body. These innovations are expected to further solidify the company's position as a leader in the wellness industry.
Key Highlights of the Patent Filings:
• Enhanced Ingredient Delivery: The new systems are designed to improve the absorption and utilization of key ingredients, including the company's flagship SOD formulations.
• Proprietary Transport Mechanisms: Cellev8's unique approach ensures that active compounds reach their intended targets more efficiently within the body.
• Broad Application: The patents cover delivery systems applicable across Cellev8's entire product range, including their popular inflammation and recovery gummies.
Impact on Product Lines
Michael Ferraro, CEO of Cellev8 Nutrition, commented on the patent filings: "These patents represent a culmination of our research and development efforts. They will not only protect our intellectual property but also pave the way for more effective and innovative wellness solutions for our customers. Imagine supplements that not only deliver powerful key ingredients more efficiently but also provides a precisely tailored blend of nutrients and critical anti-oxidants to support your body's unique needs. That's the Cellev8 difference! With our innovative approach, we're not just creating supplements - we're crafting personalized solutions for optimal health and vitality.."
The new delivery systems are expected to enhance the performance of Cellev8's existing products, including:
• Inflammation & Recovery Gummies
• Focus & Memory Gummies
• GLP1 Support Gummies
Future Prospects
With these patent filings, Cellev8 Nutrition is poised to expand its market presence with a lineup of additional products and potentially collaborate with larger nutraceutical and pharmaceutical companies interested in leveraging the benefits of their enhanced delivery process.
The company continues to focus on developing cutting-edge wellness products that promote health and vitality, serving thousands of customers, including over 40 professional and collegiate athletic teams, clients of FDA certified Zyppah products and patients/clients of publicly traded FDA approved sleep apnea company Vivos Therapeutics Inc.
For more information about Cellev8 Nutrition Inc and its innovative product line, visit www.cellev8.com
View the original press release on accesswire.com
FAQ
What patents did Cellev8 Nutrition (CELV) file in December 2024?
How will the new patents affect CELV's product line?
What is the market reach of Cellev8 Nutrition (CELV)?
What are the key features of CELV's patented delivery systems?
